H Joachim Deeg MD

PubMed

• SF3B1K700E neoantigen is a CD8+ T-cell target shared across human myeloid neoplasms.
  Melinda A Biernacki, Jessica Lok, Kim A Foster, Carrie Cummings, Stephanie Busch
  Cancer Immunology Research. 2025-06-26
• Long-term outcomes and quality of life with treosulfan-based conditioning in hematological malignancies.
  Rohtesh S Mehta, Stephanie J Lee, Ted Gooley, Laurel Thur, Ann Dahlberg
  Blood Advances. 2025-06-10
• 1 citations
  Disease Burden at the Time of Transplantation Is a Primary Predictor of Outcomes in Pediatric MDS: A Single-Center Experience.
  Ann Dahlberg, Phil Stevenson, Neel S Bhatt, Lauri Burroughs, Paul A Carpenter
  Cancers. 2025-05-13

Journal Articles

• Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom?  
  Vaughn,J.E., Anwer,F., Deeg,H.J., Vox Sang., 1/1/2016
• Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission  
  Walter,R.B., Sandmaier,B.M., Storer,B.E., Godwin,C.D., Buckley,S.A., Pagel,J.M., Sorror,M.L., Deeg,H.J., Storb,R., Appelbaum,F.R., Biol Blood Marrow Transplant, 1/1/2015
• Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation  
  Au,B.K., Gooley,T.A., Armand,P., Fang,M., Madtes,D.K., Sorror,M.L., Boeckh,M.J., Gibson,C.J., Deeg,H.J., Storb,R., Appelbaum,F.R., Chien,J.W., Martin,P.J., Biol Blood Marrow Transplant, 1/1/2015
• Treatment ethics, quality of life and health economics in the management of hematopoietic malignancies in older patients  
  Deeg,H.J., Bone Marrow Transplant, 1/1/2015
• Impact of allogeneic stem cell trans-plantation on survival of patients less than 65 years of age with primary myelofibrosis  
  Kroger,N., Giorgino,T., Scott,B.L., Ditschkowski,M., Alchalby,H., Cervantes,F., Vannucchi,A., Cazzola,M., Morra,E., Zabelina,T., Maffioli,M., Pereira,A., Beelen,D., De..., Blood, 1/1/2015
• Therapy for hematologic cancers in older patients, quality of life, and health economics: difficult decisions  
  Deeg,H.J., Steuten,L.M., JAMA Oncology, 1/1/2015
• Relapse after allogeneic hematopoietic cell transplantation for myelodysplastic syndromes: analysis of late relapse using comparative karyotype and chromosome genome a...  
  Yeung,C.C., Gerds,A.T., Fang,M., Scott,B.L., Flowers,M.E., Gooley,T., Deeg,H.J., Biol Blood Marrow Transplant, 1/1/2015
• Quantitative analysis of glycans, related genes, and proteins in two human bone marrow stromal cell lines using an integrated strategy  
  Li,X., Li,D., Pang,X., Yang,G., Deeg,H.J., Guan,F, Exp. Hematol, 1/1/2015
• Hematopoietic cell transplantation for myelodysplastic syndrome  
  Deeg,H.J., American Society of Clinical Oncology Educational Book, 1/1/2015
• SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition  
  Kim,E., Ilagan,J.O., Liang,Y., Daubner,G.M., Lee,S.C., Ramakrishnan,A., Li,Y., Chung,Y.R., Micol,J.B., Murphy,M.E., Cho,H., Kim,M.K., Zebari,A.S., Aumann,S., Park,C.Y...., Cancer Cell, 1/1/2015
• Severe refractory immune thrombocytopenia successfully treated with high-dose pulse cyclophosphamide and eltrombopag  
  Anwer,F., Yun,S., Nair A., Ahmad,Y., Krishnadashan,R., Deeg,H.J., Case Reports in Hematology, 1/1/2015
• In support of a patient-driven initiative and petition to lower the high price of cancer drugs (Commentary)  
  Tefferi,A., Kantarjian,H., Rajkumar,S.V., Baker,L.H., Abkowitz,J.L., Adamson,J.W., Advani,R.H., Allison,J., Antman,K.H., Bast,R.C., Jr., Bennett,J.M., Benz,E.J., Jr., ..., Mayo Clin. Proc, 1/1/2015
• A novel retroviral mutagenesis screen identifies prognostic genes in RUNX1 mediated myeloid leukemogenesis  
  Rae,D.T., Hocum,J.D., Bii,V., Deeg,H.J., Trobridge,G.D., Oncotarget, 1/1/2015
• Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study  
  Anderlini,P., Wu,J., Gersten,I., Ewell,M., Tolar,J., Antin,J.H., Adams,R., Arai,S., Eames,G., Horwitz,M.E., McCarty,J., Nakamura,R., Pulsipher,M.A., Rowley,S., Leifer,..., The Lancet Haematology, 1/1/2015
• Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN International Working Group  
  Kroger,N.M., Deeg,H.J., Olavarria,E., Niederwieser,D., Bacigalupo,A., Barbui,T., Rambaldi,A., Mesa,R., Tefferi,A., Griesshammer,M., Gupta,V., Harrison,C., Alchalby,H.,..., Leukemia, 1/1/2015
• Hematopoietic cell transplantation as curative therapy for patients with myelofibrosis: long-term success in all age groups  
  Deeg,H.J., Bredeson,C., Farnia,S., Ballen,K., Gupta,V., Mesa,R.A., Popat,U., Hari,P., Saber,W., Seftel,M., Tamari,R., Petersdorf,E, Biol Blood Marrow Transplant, 1/1/2015
• Treosulfan and radiation-induced cytotoxicity in myeloid cell lines and primary MDS cells  
  Zang,D.Y., Holman,Z., Marcondes,A.M., Deeg,H.J., Jacobs Journal of Hematology, 1/1/2015
• Second allogeneic hematopoietic cell transplantation for patients with Fanconi anemia and bone marrow failure  
  Ayas,M., Eapen,M., Le-Rademacher,J., Carreras,J., Abdel-Azim,H., Alter,B.P., Anderlini,P., Battiwalla,M., Bierings,M., Buchbinder,D.K., Bonfim,C., Camitta,B.M., Fasth,..., Biol Blood Marrow Transplant, 1/1/2015
• Murine xenogeneic models of myelodysplastic syndrome (MDS): an essential role for stroma cells  
  Li,X., Deeg,H.J, Exp. Hematol, 1/1/2014
• Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia  
  Eckrich,M.J., Ahn,K.W., Champlin,R.E., Coccia,P., Godder,K., Horan,J., Margolis,D., Deeg,H.J., Eapen,M, Am. J. Hematol, 1/1/2014
• Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute ...  
  Gyurkocza,B., Gutman,J., Nemecek,E.R., Bar,M., Milano,F., Ramakrishnan,A., Scott,B., Fang,M., Wood,B., Pagel,J.M., Baumgart,J., Delaney,C., Maziarz,R.T., Sandmaier,B.M..., Biol Blood Marrow Transplant, 1/1/2014
• Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation  
  Castilla-Llorente,C., Martin,P.J., McDonald,G.B., Storer,B.E., Appelbaum,F.R., Deeg,H.J., Mielcarek,M., Shulman,H., Storb,R., Nash,R.A., Bone Marrow Transplant, 1/1/2014
• Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statisti...  
  Lionberger,J.M., Pagel,J.M., Sandhu,V.K., Xie,H., Shadman,M., Mawad,R., Boehm,A., Dean,C., Shannon-Dorcy,K., Scott,B.L., Deeg,H.J., Becker,P.S., Hendrie,P.C., Walter,R..., Br. J. Haematol, 1/1/2014
• Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis  
  Gupta,V., Gotlib,J., Radich,J.P., Kroger,N.M., Rondelli,D., Verstovsek,S., Deeg,H.J., Biol Blood Marrow Transplant, 1/1/2014
• Acute phase protein, a1-antitrypsin--a novel regulator of angiopoietin-like protein 4 transcription and secretion  
  Frenzel,E., Wrenger,S., Immenschuh,S., Koczulla,R., Mahadeva,R., Deeg,H.J., Dinarello,C.A., Welte,T., Marcondes,A.M., Janciauskiene,S., J. Immunol, 1/1/2014
• Join now to see all

Books/Book Chapters

• Thomas' Hematopoietic Cell Transplantation 
  Chapter: Hematopoietic cell transplantation for myelodysplastic syndromes and myeloproliferative neoplasms 
  Page 613 - 624Deeg,H.J.Editors: Forman,S.J., Negrin,R.S., Antin,J.H., and Appelbaum,F.R..Wiley-BlackwellEdition 5th,2016
• Novel Insights into Myelofibrosis Pathophysiology and Treatment 
  Chapter: When and how to transplant patients with myelofibrosis 
  Deeg,H.J., Sala-Torra,O., Scott,B.L.Editors: Verstovsek,S..Future Science Group, London2015
• Hamatopoietische Stammzellen 
  Chapter: Transplantatversagen, krankheitsrezidiv, zweittransplantation 
  Page 196 - 199Platzbecker,U., Deeg,H.J.Editors: Herr,W., Theobald,M., Ehninger,G., Einsele,H., and Meyer,R.G.Deutscher arzte-Verlag GmbH, Koln2015
• Hamatopoietische Stammzellen 
  Chapter: Sekundarmalignome 
  Page 200 - 206Wagner,E.M., Deeg,H.J.Editors: Herr,W., Theobald,M., Ehninger,G., Einsele,H., and Meyer,R.G..Deutscher arzte-Verlag GmbH, Koln2015
• Neoplastic Diseases of the Blood 
  Chapter: Alternative sources of hematopoietic stem cells and their clinical applications 
  Page 1289 - 1306Gutman,J., Heimfeld,S., Deeg,H.J.Editors: Wiernik,P., Goldman,J., Dutcher,J., and Kyle,R.Cambridge University Press, Cambridge, UKEdition Fift,2013
• Myelodysplastic Syndromes 
  Editors: Deeg,H.J., Bowen,D.T., Gore,S.D., Haferlach,T., Le Beau,M.M., Niemeyer,C..Springer-Verlag, Berlin Heidelberg2013
• Myelodysplastic Syndromes 
  Chapter: MDS stem cell biology 
  Page 73 - 84Greenblatt,S.M., Deeg,H.J., Nimer,S.D.Editors: Deeg,H.J., Bowen,D.T., Gore,S.D., Haferlach,T., Le Beau,M.M., and Niemeyer,C..Springer-Verlag, Berlin Heidelberg2013
• Hematopoietic cell transplantation (HCT). 
  Chapter: Hematopoietic cell transplantation (HCT). 
  Page 211 - 228Deeg,H.JEditors: Deeg,H.J., Bowen,D.T., Gore,S.D., Haferlach,T., Le Beau,M.M., and Niemeyer,C..Springer-Verlag, Berlin Heidelberg2013
• Clinical Decision Support: Hematology 
  Chapter: Hematopoeitic cell transplantation for non-malignant diseases 
  Deeg,H.J.Editors: Benz,E.J., Berliner,N., Brodsky,R.A., LaCasce,A.S., and Moake,J.L..Decision Support in Medicine, LLC, Wilmington, DE2012
• Myeloproliferative Neoplasms: Biology and Therapy 
  Chapter: Hematopoietic cell transplantation for myelofibrosis 
  Page 139 - 150Kerbauy,D.M.B., Deeg,H.J.Editors: Verstovsek,S. and Tefferi,A..Humana Press, New York, NY2011
• Transplant Infections 
  Chapter: Introduction to hematopoietic stem cell transplantation 
  Page 1 - 12Rezvani,A.R., Deeg,H.J.Editors: Bowden,R., Ljungman,P., and Snydman,D.R..Lippincott Williams & Wilkins, Philadelphia, PAEdition Thir,2010
• Hematopoietic Stem Cell Transplantation in Clinical Practice 
  Chapter: Acute graft-versus-host disease 
  Page 387 - 400Deeg,H.J., Flowers,M.E.D.Editors: Treleaven,J. and Barrett,A.J..Elsevier Ltd, Edinburgh, UK2009
• Hematopoietic Stem Cell Transplantation in Clinical Practice 
  Chapter: Chronic graft-versus-host disease 
  Page 401 - 407Flowers,M.E.D., Deeg,H.JEditors: Treleaven,J. and Barrett,A.J..Elsevier Ltd, Edinburgh, UK2009
• Hematology Basic Principles and Practice 
  Chapter: Hematopoietic cell transplantation for acquired nonmalignant diseases and myelodysplastic syndrome 
  Page 1561 - 1576Scott,B.L., Deeg,H.J.Editors: Hoffman,R., Benz,E.J., Jr., Shattil,S.J., Furie,B., Silberstein,L.E., McGlave,P., and Heslop,H..Churchill Livingstone Elsevier, Philadelphia, PAEdition 5th,2009
• Thomas' Hematopoietic Cell Transplantation 
  Chapter: Hematopoietic cell transplantation for myelodysplastic syndrome and myeloproliferative disorders 
  Page 827 - 844Deeg,H.J.Editors: Appelbaum,F.R., Forman,S.J., Negrin,R.S., and Blume,K.G..Wiley-Blackwell, Oxford, UKEdition Four,2009
• Thomas' Hematopoietic Cell Transplantation 
  Chapter: Delayed nonmalignant complications after hematopoietic cell transplantation 
  Page 1620 - 1637Flowers,M.E.D., Deeg,H.J.Editors: Appelbaum,F.R., Forman,S.J., Negrin,R.S., and Blume,K.G..Wiley-Blackwell, Oxford, UKEdition Four,2009
• Chronic Graft Versus Host Disease: Interdisciplinary Management 
  Chapter: Secondary malignancies and other late effects 
  Page 326 - 334Socie,G., Deeg,H.J.Editors: Vogelsang,G.B. and Pavletic,S.Z..Cambridge University Press, New York NY2009
• American Society of Clinical Oncology 2009 Educational Book 
  Chapter: Allogeneic hematopoietic cell transplantation in older patients with myelodysplastic syndrome 
  Page 420 - 424Deeg,H.J.American Society of Clinical Oncology, Alexandria, VA2009
• Hematopoietic Stem Cell Transplantation 
  Chapter: Acute graft-versus-host disease 
  Page 589 - 620Benesch,M., Deeg,H.J.Editors: Soiffer,R.J..Humana Press, Totowa, NJEdition Seco,2008
• Hematopoietic Stem Cell Transplantation 
  Chapter: Allogeneic hematopoietic cell transplantation for patients with myelodysplastic syndrome and myeloproliferative disorders 
  Page 167 - 182Ramakrishnan,A., Deeg,H.J.Editors: Soiffer,R.J..Humana Press, Totowa, NJEdition Seco,2008
• Cancer Survivorship: Today and Tomorrow 
  Chapter: Medical and psychosocial issues in transplant survivors 
  Page 188 - 214Syrjala,K.L., Martin,P., Deeg,J., Boeckh, M.Editors: Ganz,P.A..Springer Science+Business Media, LLC, New York NY2007
• Oncology: An Evidence-Based Approach 
  Chapter: Medical and psychosocial issues in transplant survivors 
  Page 1902 - 1928Syrjala,K.L., Martin,P., Deeg,J., Boeckh, MEditors: Chang,A.E., Ganz,P.A., Hayes,D.F., Kinsella,T.J., Pass,H.I., Schiller,J.H., Stone,R.M., and Strecher,V.J..Springer Science + Business Media, Inc., New York, NY2006
• Myelodysplastic Syndromes: Clinical and Biological Advances 
  Chapter: Hematopoietic cell transplantation for myelodysplastic syndromes 
  Page 243 - 262Deeg,H.J., Scott,B.Editors: Greenberg, P.L..Cambridge University Press, Cambridge, UK2006
• Hematologic Malignancies: Myelodysplastic Syndromes 
  Editors: Deeg,H.J., Bowen,D.T., Gore,S.D., Haferlach,T., Le Beau,M.M., Niemeyer,C..Springer, Heidelberg, Germany2006
• Hematologic Malignancies: Myelodysplastic Syndromes 
  Chapter: Second malignancies 
  Page 135 - 136Deeg,H.J.Editors: Deeg,H.J., Bowen,D.T., Gore,S.D., Haferlach,T., Le Beau,M.M., and Niemeyer,C.Springer, Heidelberg, Germany2006
• Join now to see all

Abstracts/Posters

• Determining eligibility for autologous hematopoietic cell transplantation
  Holmberg,L.A., Deeg,H.J., Sandmaier,B.M., 1/1/2011

Other

• Hematopoietic cell transplantation for myelofibrosis 
  Gerds,A.T., Scott,B.L., Deeg,H.J., Myeloproliferative Neoplasms: A Clinicians Guide App (eBook),
  1/15/2014
• Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience 
  Yusuf, U., Frangoul, H.A., Gooley, T.A., Woolfrey, A.E., Carpenter, P.A., Andrews, R.G., Deeg, H.J., Appelbaum, F.R., Anasetti, C., Storb, R., Sanders, J.E, Bone Marrow Transplant. Advance online
  1/2/2004
• Hematopoietic cell transplantation for myelodysplastic syndromes (MDS). 
  Scott,B., Deeg,H.J., The MDS News
  1/1/2004
• Myelodysplastic Syndromes 
  Greenberg, P.L., Baer, M., Bennett, J.M., Bloomfield, C.D., DeCastro, C.M., Deeg, H.J., Devetten, M., Emanuel, P.D., Erba, H.P., Estey, E., Foran, J., Gore, S.D., Mill..., National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology v.1. 2005
  http://www.nccn.org/professionals/physician_gls/PDF/mds.pdf
  1/1/2004
• Ueber das Rectum-Carcinom unter besonderer Beruecksichtigung des TNM-Systems, Inaugural Dissertation 
  Deeg, H.J., University of Bonn, School of Medicine
  1/1/1972
• Determining eligibility for allogeneic hematopoietic cell transplantation 
  Deeg HJ, Sandmaier BM
  http://www.uptodate.com/contents/determining-eligibility-for-allogeneic-hematopoietic-cell-transplan
  UpToDate, Wolters Kluwer Health - 2013-03-29
• Determining eligibility for autologous hematopoietic cell transplantation 
  Deeg HJ, Sandmaier BM, Holmberg LA
  http://www.uptodate.com/contents/determining-eligibility-for-autologous-hematopoietic-cell-transplan
  UpToDate, Wolters Kluwer Health - 2012-03-06
• Join now to see all